Amyloid Neuropathies, Familial
6 clinical trials · Condition
◉ Watch Amyloid Neuropathies, Familial
| Record | Firm | Date |
|---|---|---|
| Early and Systematic Screening in Chronic Neuropathy (NCT03720275) | University Hospital, Bordeaux | 2018-11-27 |
| Monitoring of Early Disease Progression in Hereditary Transthyretin Amyloidosis (NCT03431896) | The Cleveland Clinic | 2018-02-01 |
| ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC) (NCT02319005) | Alnylam Pharmaceuticals | 2014-12-01 |
| APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis (NCT01960348) | Alnylam Pharmaceuticals | 2013-11-01 |
| Expanded Access Protocol of Patisiran for Patients With Hereditary ATTR Amyloidosis (hATTR) (NCT02939820) | Alnylam Pharmaceuticals |
Track Amyloid Neuropathies, Familial automatically
Every clearance here is in the API, with alerts when new ones post.